Farallon Capital Management LLC Astrazeneca PLC Transaction History

Farallon Capital Management LLC

$19.9 Billion
Q3 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$66.81 - $80.83 $63.5 Million - $76.8 Million	950,000 Added 65.08%	2,409,718 $188 Million
Q1 2024 May 15, 2024	SELL	$61.03 - $69.57 $144 Million - $165 Million	-2,364,573 Reduced 61.83%	1,459,718 $98.9 Million
Q4 2023 Feb 14, 2024	BUY	$61.89 - $69.28 $237 Million - $265 Million	3,824,291 New	3,824,291 $258 Million
Q3 2023 Nov 14, 2023	BUY	$64.85 - $71.7 $393 Million - $434 Million	6,059,553 New	6,059,553 $410 Million
Q2 2023 Aug 14, 2023	BUY	$69.91 - $75.81 $13.4 Million - $14.6 Million	192,000 Added 3.27%	6,059,553 $434 Million
Q1 2023 May 15, 2023	SELL	$63.15 - $71.6 $562,603 - $637,884	-8,909 Reduced 0.15%	5,867,553 $407 Million
Q4 2022 Feb 14, 2023	BUY	$54.21 - $70.44 $15.8 Million - $20.5 Million	291,500 Added 5.22%	5,876,462 $398 Million
Q3 2022 Nov 14, 2022	BUY	$53.02 - $135.75 $50.6 Million - $130 Million	955,000 Added 20.63%	5,584,962 $306 Million
Q2 2022 Aug 15, 2022	BUY	$59.26 - $71.14 $62.4 Million - $75 Million	1,053,778 Added 29.47%	4,629,962 $306 Million
Q1 2022 May 16, 2022	BUY	$55.72 - $67.12 $93.1 Million - $112 Million	1,670,029 Added 87.61%	3,576,184 $237 Million
Q4 2021 Feb 14, 2022	BUY	$54.02 - $63.83 $84.9 Million - $100 Million	1,572,155 Added 470.71%	1,906,155 $111 Million
Q3 2021 Nov 15, 2021	SELL	$55.56 - $60.79 $113 Million - $124 Million	-2,041,785 Reduced 85.94%	334,000 $20.1 Million
Q3 2019 Nov 14, 2019	SELL	$40.12 - $45.47 $69.2 Million - $78.4 Million	-1,724,215 Reduced 42.05%	2,375,785 $106 Million
Q2 2019 Aug 14, 2019	BUY	$37.28 - $41.68 $8.02 Million - $8.96 Million	215,000 Added 5.53%	4,100,000 $169 Million
Q4 2018 Feb 14, 2019	BUY	$36.86 - $41.49 $17.1 Million - $19.3 Million	465,000 Added 13.6%	3,885,000 $148 Million
Q3 2018 Nov 14, 2018	SELL	$34.76 - $39.72 $14.9 Million - $17.1 Million	-430,000 Reduced 11.17%	3,420,000 $135 Million
Q2 2018 Aug 14, 2018	BUY	$34.55 - $37.05 $9.85 Million - $10.6 Million	285,000 Added 7.99%	3,850,000 $135 Million
Q1 2018 May 15, 2018	SELL	$32.97 - $36.63 $6.59 Million - $7.33 Million	-200,000 Reduced 5.31%	3,565,000 $125 Million
Q4 2017 Feb 14, 2018	BUY	$32.09 - $34.78 $18.8 Million - $20.3 Million	585,000 Added 18.4%	3,765,000 $131 Million
Q3 2017 Nov 14, 2017	BUY	$28.96 - $34.0 $92.1 Million - $108 Million	3,180,000	3,180,000 $108 Million

Others Institutions Holding AZN

# of Institutions

1,361

Shares Held

475M

Call Options Held

5.39M

Put Options Held

3.75M

Price T Rowe Associates Inc Baltimore, MD

62.9M
Shares

$4.05 Billion
0.56% of portfolio
Primecap Management CO Pasadena, CA

42M
Shares

$2.71 Billion
2.45% of portfolio
Wellington Management Group LLP Boston, MA

37.2M
Shares

$2.4 Billion
0.52% of portfolio
Capital International Investors Los Angeles, CA

36.8M
Shares

$2.37 Billion
0.57% of portfolio
Franklin Resources Inc San Mateo, CA

19.1M
Shares

$1.23 Billion
0.45% of portfolio

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $200B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Farallon Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Farallon Capital Management LLC with notifications on news.

Account